Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG4.L Regulatory News (MIG4)

  • There is currently no data for MIG4

Interim Management Statement

15 Nov 2023 15:00

RNS Number : 5916T
Mobeus Income & Growth 4 VCT PLC
15 November 2023

MOBEUS INCOME & GROWTH 4 VCT PLC

("the Company")

LEI: 213800IFNJ65R8AQW943

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2023

Mobeus Income & Growth 4 VCT plc presents an Interim Management Statement for the quarter ended 30 September 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30September 2023

(unaudited)

At 30 June 2023

(unaudited)

Net assets attributable to shareholders

£86.63 million

£84.23 million

Shares in issue

110,556,762

110,556,762

Net asset value (NAV) per share

78.36 pence

76.19 pence

Cumulative dividends paid

158.20 pence

158.20 pence

Cumulative Total return (net asset value basis) per share since inception

236.52 pence

234.39 pence

The NAV per share has decreased by 2.17 pence in the quarter (an increase of 2.85% from the opening NAV per share).

INVESTMENT ACTIVITY DURING THE PERIOD

New Investment during the period

On 26 July 2023, the Company completed a new investment of £0.40 million into Mable Therapy, a digital health platform for speech therapy and counselling for children and young adults.

On 3 August 2023, the Company completed a new investment of £0.39 million into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.

Further Investments during the period

On 4 July 2023, a follow on equity investment of £0.33 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.

On 11 August 2023, a follow on loan investment of £0.12 million was made into Orri, an intensive day care provider for adults with eating disorders.

INVESTMENT ACTIVITY AFTER THE PERIOD END

There has been no activity post-quarter.

SHARE BUYBACK AFTER THE PERIOD END

On 17 October 2023, the Company purchased 525,821 of its own ordinary shares at a price of 66.68 pence per share.

All shares bought back by the Company were subsequently cancelled.

DIVIDEND DECLARED AFTER THE PERIOD END

On 5 October 2023, a second interim dividend of 6.00 pence per share in respect of the year ending 31 December 2023 was declared and was paid on 8 November 2023 to all Shareholders whose names were on the register on 13 October 2023. Payment of this interim dividend will reduce NAV per share (shown above) to 72.36 pence and increase cumulative dividends paid to 164.20 pence per share.

DIVIDEND INVESTMENT SCHEME ("DIS")

On 8 November 2023, 1,515,451 shares were allotted through the DIS during the period at a price of 70.19 pence per share.

Please note that all of the above information is unaudited.

Other than as described above, there were no material events during the period and to the date of this announcement.

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCZELFFXFLLFBV
Date   Source Headline
16th Apr 20205:45 pmRNSAnnual Financial Report
16th Apr 20205:45 pmRNSDividend Investment Scheme - Recommencement
2nd Apr 20205:10 pmRNSIssue of Equity
2nd Apr 202010:00 amRNSDividend Declaration
30th Mar 202012:51 pmRNSPublication of Suppl.Prospcts
27th Mar 20207:00 amRNSNet Asset Value(s)
25th Feb 20203:15 pmRNSPublication of Suppl.Prospcts
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
7th Feb 20206:40 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:37 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:36 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:34 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:30 pmRNSPublication of Suppl.Prospcts
3rd Feb 202011:30 amRNSTotal Voting Rights
8th Jan 20204:31 pmRNSFundraising Update
8th Jan 20204:20 pmRNSIssue of Equity & Total Voting Rights
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
13th Dec 20195:50 pmRNSDividend Declaration
13th Dec 20199:15 amRNSTransaction in Own Shares
27th Nov 20194:15 pmRNSInterim Management Statement - 3rd Quarter Results
27th Nov 20191:52 pmRNSDividend Declaration
26th Nov 20195:00 pmRNSDirectorate Change
19th Nov 201912:00 pmRNSFundraising Update
25th Oct 20194:00 pmRNSPublication of a Prospectus
21st Oct 201912:57 pmRNSDirector Declaration
11th Oct 20193:00 pmRNSResult of Meeting
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares
10th Sep 20195:00 pmRNSFundraising Update, Circular and General Meetings
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
14th Aug 201911:05 amRNSNational Storage Mechanism
8th Aug 201910:54 amRNSHalf-year Report
31st Jul 20197:00 amRNSReduction of Capital
29th Jul 201911:00 amRNSShare buyback policy objective
29th Jul 20197:00 amRNSIntention to launch offers for subscription
3rd Jul 201911:33 amRNSRealisation of investment
20th May 20199:28 amRNSTransaction in Own Shares
15th May 201910:16 amRNSTransaction in Own Shares
13th May 201910:10 amRNS1st Quarter Results - Interim Management Statement
10th May 20192:08 pmRNSDirectorate Change
10th May 20192:05 pmRNSResult of AGM
27th Mar 201910:48 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.